PLSE Pulse Biosciences, Inc - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$47,90
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$12,5652 haftanın en düşüğü
$58,9052 haftanın en yükseği
Piyasa Değeri (MRQ)
$3.39B
Gelir
$350.0K
rozetleriniz
52 Haftlık Aralık
$13–$59
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$54
P/E
·
ROE
·
Net Kâr Marjı
-6755.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PLSE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$47.90
Piyasa Değeri (MRQ)
$3.39B
Gelir
$350.0K
52 Haftlık Aralık
$13–$59
PLSE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$350.0K2020-12-31 → 2025-12-31
Serbest Nakit Akışı·2016-12-31 → 2023-12-31
Net kar marjı-6755.8%2016-12-31 → 2022-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PLSE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| F/S (TTM) | 2861.9 | · | 3.7 | Aşırı değerli | |
| F/D (MRQ) | 34.15Y ort. ≈-6.1 | ≈-6.1 | 4.0 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -55.25Y ort. ≈-10.2 | ≈-10.2 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -55.55Y ort. ≈-10.3 | ≈-10.3 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 34.25Y ort. ≈12.6 | ≈12.6 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PLSE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -7007.8% | · | 2.6% | Zayıf | |
| Net Kâr Marjı (TTM) | -6755.8% | · | 2.5% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PLSE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 9.65Y ort. ≈7.1 | ≈7.1 | 4.1 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PLSE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -20.6% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PLSE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$3.0K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
15.6%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $-0.36 | $-0.37 | 2.0% |
| 31 Mart 2026 | May 7, 2026 | $-0.24 | $-0.32 | 25.3% |
| 31 Aralık 2025 | $-0.26 | $-0.32 | 17.8% | |
| 30 Eylül 2025 | $-0.29 | $-0.32 | 8.3% | |
| 30 Haziran 2025 | $-0.20 | $-0.27 | 24.6% | |
| 31 Mart 2025 | $-0.17 | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $350.0K | $0 | $0 | $700.0K | $1M | $0 | |
| Cost of Revenue | $539.0K | $0 | $0 | $12M | $2M | $0 | |
| R&D Expense | $45M | $32M | $28M | $21M | $29M | $26M | |
| SG&A Expense | $32M | $24M | $16M | $14M | $19M | $16M | |
| Operating Expenses | $77M | $56M | $44M | $59M | $64M | $50M | |
| Operating Income | $-77M | $-56M | $-44M | $-58M | $-63M | $-50M | |
| Interest Income | · | · | · | · | · | $114.0K | |
| Other Non-op | $-52.0K | $-18.0K | $1M | $-448.0K | $-646.0K | $114.0K | |
| Pretax Income | $73M | $54M | $-42M | $-59M | $-64M | $-50M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-73M | $-54M | $-42M | $-59M | $-64M | $-50M | |
| EPS (Basic) | $-1.08 | $-0.92 | $-0.85 | $-1.72 | $-2.28 | $-2.14 | |
| Shares (Basic) | 67,395,339 | 58,397,597 | 49,737,000 | 33,935,000 | 27,964,000 | 23,248,000 | |
| EBITDA | · | · | $-44M | $-58M | $-63M | $-50M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $81M | $118M | $44M | $61M | $44M | $12M | |
| Short-term Investments | · | · | · | · | · | $8M | |
| Receivables | $274.0K | $0 | · | $0 | $61.0K | · | |
| Inventory | $136.0K | $0 | · | $0 | $6M | · | |
| Prepaid Expense | $2M | $1M | $963.0K | $1M | $963.0K | $2M | |
| Current Assets | $83M | $119M | $45M | $62M | $45M | $22M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $4M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $2M | $2M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $575.0K | $1M | $2M | $3M | $2M | $4M | |
| Other Non-current Assets | $691.0K | $677.0K | $365.0K | $365.0K | $365.0K | $365.0K | |
| Total Assets | $95M | $132M | $59M | $78M | $59M | $41M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $4M | $7M | $4M | $3M | $4M | $5M | |
| Short-term Debt | · | · | $0 | $917.0K | $436.0K | · | |
| Current Liabilities | $8M | $10M | $7M | $6M | $7M | $8M | |
| Capital Leases | $6M | $8M | $8M | $9M | $8M | $11M | |
| Total Liabilities | $14M | $18M | $15M | $80M | $15M | $18M | |
| Total Debt | · | · | $0 | $0 | $436.0K | · | |
| Common Stock | $68.0K | $66.0K | $55.0K | $37.0K | $55.0K | $25.0K | |
| Retained Earnings | $-463M | $-390M | $-337M | $-295M | $-337M | $-173M | |
| AOCI | · | $0 | $0 | $0 | $0 | $-1.0K | |
| Stockholders' Equity | $81M | $115M | $44M | $-2M | $44M | $23M | |
| Liabilities + Equity | $95M | $132M | $59M | $78M | $59M | $41M | |
| Shares Outstanding | 67,839,689 | 65,925,503 | 55,144,000 | 37,235,000 | 55,144,000 | 25,550,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $21M | $14M | $7M | $5M | $15M | $10M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $665.0K | $666.0K | $665.0K | $665.0K | $666.0K | $665.0K | |
| Operating Cash Flow | $-54M | $-36M | $-33M | $-47M | $-54M | $-35M | |
| CapEx | $315.0K | $125.0K | $121.0K | $401.0K | $437.0K | $441.0K | |
| Investing Cash Flow | $-335.0K | $-125.0K | $-121.0K | $-401.0K | $8M | $10M | |
| Stock Issued | · | · | $0 | $15M | $57M | $29M | |
| Net Stock Activity | · | · | $0 | $15M | $57M | · | |
| Financing Cash Flow | $17M | $110M | $16M | $80M | $63M | $31M | |
| Net Change in Cash | $-37M | $74M | $-17M | $33M | $16M | $6M | |
| Free Cash Flow | · | · | $-33M | $-47M | $-55M | $-36M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -8293.9% | -4443.9% | -43728.9% | |
| Net Margin | · | · | · | -8357.9% | -4489.4% | -43728.9% | |
| Pretax Margin | · | · | · | -8357.9% | -4489.4% | -43728.9% | |
| EBITDA Margin | · | · | · | -8293.9% | -4443.9% | -43728.9% | |
| ROA | · | · | -61.6% | -85.4% | -133.3% | -119.8% | |
| ROE | · | · | -87.5% | -2969.0% | -153.3% | -179.3% | |
| ROIC | · | · | -98.2% | 2582.6% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 6.8 | 10.4 | 4.3 | 2.9 | |
| Quick Ratio | · | · | 6.6 | 10.2 | 3.4 | 2.7 | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.0 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | 4.1 | 0.2 | · | |
| Receivables Turnover | · | · | · | 23.0 | 46.5 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $0.80 | $-0.06 | $1.20 | $0.90 | |
| Cash / Share | · | · | $0.80 | $1.64 | $0.96 | $0.49 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -50.6% | · | · | |
| Revenue CAGR 3Y | -20.6% | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $350.0K | $0 | $0 | $700.0K | $1M | $0 | |
| Net Income TTM | $-73M | $-54M | $-42M | $-59M | $-64M | $-50M | |
| Market Cap | · | · | $675M | $103M | $440M | $610M | |
| Enterprise Value | · | · | $631M | $42M | $412M | · | |
| P/S | · | · | · | 147.3 | 310.4 | · | |
| P/B | · | · | 15.2 | -45.9 | 12.3 | 26.6 | |
| P / Tangible Book | 12.1 | 10.4 | 17.0 | · | 11.1 | 37.6 | |
| P / Cash Flow | · | · | -20.4 | -2.2 | -8.1 | -17.2 | |
| P / FCF | · | · | -20.4 | -2.2 | -8.1 | -17.0 | |
| EV / EBITDA | · | · | -14.5 | -0.7 | -6.5 | · | |
| EV / FCF | · | · | -19.0 | -0.9 | -7.6 | · | |
| EV / Revenue | · | · | · | 60.0 | 290.5 | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $434.0K | $401.0K | $264.0K | $86.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Cost of Revenue | $273.0K | $370.0K | $260.0K | $279.0K | $0 | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | $1M | $8M | |
| R&D Expense | $17M | $13M | $11M | $11M | $12M | $10M | $11M | $8M | $7M | $7M | $8M | $7M | $7M | $6M | $4M | $5M | |
| SG&A Expense | $8M | $7M | $7M | $9M | $8M | $8M | $10M | $6M | $4M | $4M | $5M | $4M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $26M | $20M | $19M | $20M | $20M | $18M | $20M | $14M | $12M | $11M | $13M | $11M | $10M | $10M | $9M | $18M | |
| Operating Income | $-25M | $-19M | $-18M | $-20M | $-20M | $-18M | $-20M | $-14M | $-12M | $-11M | $-13M | $-11M | $-10M | $-10M | $-9M | $-18M | |
| Other Non-op | $15.0K | $-24.0K | $-2M | $-19.0K | $-22.0K | $-6.0K | $-838.0K | $-1.0K | $343.0K | $478.0K | $600.0K | $686.0K | $317.0K | $-239.0K | $-452.0K | $-14.0K | |
| Pretax Income | · | · | · | · | $-19M | $-17M | $88M | $-13M | $-11M | $-10M | $-12M | $-11M | $-10M | $-10M | $-9M | $-18M | |
| Income Tax | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-25M | $-19M | $-17M | $-19M | $-19M | $-17M | $-19M | $-13M | $-11M | $-10M | $-12M | $-11M | $-10M | $-10M | $-9M | $-18M | |
| EPS (Basic) | $-0.36 | $-0.27 | $-0.26 | $-0.29 | $-0.28 | $-0.25 | $-0.33 | $-0.21 | $-0.20 | $-0.18 | $-0.18 | $-0.19 | $-0.22 | $-0.26 | $-0.21 | $-0.49 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.49 | |
| Shares (Basic) | 69,200,020 | 67,994,566 | · | 67,385,000 | 67,275,608 | 67,125,967 | · | 61,066,000 | 57,180,000 | 57,124,000 | · | 56,866,000 | 46,086,000 | 37,390,000 | · | 37,158,000 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 37,158,000 | |
| EBITDA | $-25M | $-19M | · | $-20M | $-20M | $-18M | · | $-14M | $-12M | $-11M | · | $-11M | $-10M | $-10M | · | $-18M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $68M | $81M | $95M | $106M | $119M | $118M | $79M | $26M | $35M | $44M | $50M | $59M | $54M | $61M | $69M | |
| Receivables | $122.0K | $157.0K | $274.0K | $15.0K | · | · | $0 | · | · | · | · | · | · | · | · | $5.0K | |
| Inventory | $236.0K | $206.0K | $136.0K | $57.0K | $51.0K | $30.0K | $0 | · | · | · | · | · | · | · | · | $750.0K | |
| Prepaid Expense | $4M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $964.0K | $963.0K | $1M | $1M | $849.0K | $1M | $1M | |
| Current Assets | $106M | $71M | $83M | $97M | $108M | $121M | $119M | $80M | $27M | $36M | $45M | $52M | $60M | $55M | $62M | $71M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $222.0K | $408.0K | $575.0K | $741.0K | $907.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Other Non-current Assets | $403.0K | $575.0K | $691.0K | $705.0K | $677.0K | $678.0K | $677.0K | $646.0K | $714.0K | $365.0K | $365.0K | $365.0K | $365.0K | $365.0K | $365.0K | $365.0K | |
| Total Assets | $116M | $82M | $95M | $109M | $120M | $133M | $132M | $93M | $40M | $49M | $59M | $66M | $75M | $70M | $78M | $88M | |
| Accounts Payable | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $6M | $5M | $4M | $5M | $5M | $4M | $7M | $4M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $801.0K | $917.0K | · | |
| Current Liabilities | $11M | $10M | $8M | $10M | $9M | $8M | $10M | $7M | $6M | $5M | $7M | $5M | $6M | $7M | $6M | $7M | |
| Capital Leases | $5M | $6M | $6M | $6M | $7M | $7M | $8M | $7M | $7M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | |
| Total Liabilities | $16M | $15M | $14M | $16M | $16M | $15M | $18M | $14M | $13M | $13M | $15M | $14M | $14M | $81M | $80M | $81M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $801.0K | · | · | |
| Common Stock | $71.0K | $68.0K | $68.0K | $68.0K | $67.0K | $67.0K | $66.0K | $62.0K | $55.0K | $55.0K | $55.0K | $55.0K | $55.0K | $37.0K | $37.0K | $37.0K | |
| Retained Earnings | $-507M | $-482M | $-463M | $-446M | $-426M | $-407M | $-390M | $-371M | $-358M | $-347M | $-337M | $-325M | $-314M | $-305M | $-295M | $-286M | |
| AOCI | · | · | · | · | · | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Stockholders' Equity | $100M | $66M | $81M | $93M | $104M | $118M | $115M | $79M | $27M | $36M | $44M | $52M | $60M | $-11M | $-2M | $6M | |
| Liabilities + Equity | $116M | $82M | $95M | $109M | $120M | $133M | $132M | $93M | $40M | $49M | $59M | $66M | $75M | $70M | $78M | $88M | |
| Shares Outstanding | 70,799,962 | 68,225,067 | 67,839,689 | 67,738,000 | 67,278,000 | 67,274,000 | 65,925,503 | 61,516,000 | 55,228,000 | 55,225,000 | 55,144,000 | 54,991,000 | 54,771,000 | 37,593,000 | 37,235,000 | 37,228,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $2M | $5M | $6M | $5M | $6M | $7M | $3M | $2M | $2M | $3M | $2M | $1M | $896.0K | $748.0K | $723.0K | |
| Amort. of Intangibles | $166.0K | $167.0K | $166.0K | $166.0K | $167.0K | $166.0K | $166.0K | $167.0K | $166.0K | $167.0K | $166.0K | $166.0K | $166.0K | $167.0K | $166.0K | $166.0K | |
| Operating Cash Flow | $-19M | $-15M | $-15M | $-13M | $-13M | $-14M | $-9M | $-9M | $-8M | $-10M | $-7M | $-10M | $-9M | $-7M | $-8M | $-11M | |
| CapEx | $90.0K | $33.0K | $105.0K | $62.0K | $103.0K | $45.0K | $53.0K | $38.0K | $29.0K | $5.0K | $43.0K | $23.0K | $16.0K | $39.0K | $41.0K | $62.0K | |
| Investing Cash Flow | $-90.0K | $-33.0K | $-105.0K | $-62.0K | $-123.0K | $-45.0K | $-53.0K | $-38.0K | $-29.0K | $-5.0K | $-43.0K | $-23.0K | $-16.0K | $-39.0K | $-41.0K | $-62.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | $-29.0K | $-70.0K | |
| Financing Cash Flow | $52M | $2M | $381.0K | $2M | $0 | $15M | $48M | $62M | $-265.0K | $305.0K | $804.0K | $2M | $14M | $-432.0K | $-17.0K | $65M | |
| Net Change in Cash | $33M | $-12M | $-14M | $-11M | $-13M | $1M | $39M | $53M | $-9M | $-9M | $-6M | $-8M | $5M | $-7M | $-8M | $54M | |
| Free Cash Flow | · | $-15M | · | · | · | $-14M | · | · | · | $-10M | · | · | · | $-7M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5823.0% | -4775.6% | · | -23682.6% | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -5681.3% | -4633.7% | · | -22540.7% | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -5823.0% | -4775.6% | · | -23682.6% | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -20.9% | -17.3% | · | -19.2% | -23.9% | -18.4% | · | -16.0% | -19.8% | -17.0% | · | -13.8% | -17.2% | -17.9% | · | -23.3% | |
| ROE | -24.2% | -20.1% | · | -22.6% | -29.2% | -21.7% | · | -19.3% | -26.0% | -79.1% | · | -36.2% | -23.6% | -193.5% | · | -67.3% | |
| ROIC | · | · | · | · | -19.4% | -15.2% | · | -17.3% | -43.5% | -29.2% | · | -21.6% | -16.9% | 96.9% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.6 | 7.3 | · | 10.0 | 12.0 | 15.6 | · | 11.9 | 4.6 | 7.1 | · | 9.5 | 10.7 | 7.9 | · | 10.2 | |
| Quick Ratio | 9.3 | 7.0 | · | 9.8 | 11.8 | 15.4 | · | 11.7 | 4.4 | 6.9 | · | 9.3 | 10.5 | 7.7 | · | 9.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | -0.1 | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 1.9 | 3.1 | · | 0.7 | · | · | · | · | · | · | · | · | · | · | · | 3.3 | |
| Receivables Turnover | 6.7 | 4.5 | · | 8.6 | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.41 | $0.97 | · | $1.37 | $1.55 | $1.76 | · | $1.29 | $0.49 | $0.66 | · | $0.95 | $1.10 | $-0.28 | · | $0.17 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash / Share | $1.44 | $1.00 | · | $1.41 | $1.58 | $1.77 | · | $1.28 | $0.47 | $0.63 | · | $0.92 | $1.07 | $1.44 | · | $1.86 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $751.0K | · | $86.0K | $0 | $0 | · | $0 | $0 | $0 | · | $-9.0K | $-9.0K | $256.0K | · | $2M | |
| Net Income TTM | $-80M | $-75M | · | $-75M | $-68M | $-60M | · | $-46M | $-44M | $-43M | · | $-39M | $-47M | $-51M | · | $-65M | |
| Market Cap | $1.96B | $1.47B | · | $1.20B | $1.02B | $1.08B | · | $1.08B | $618M | $481M | · | $222M | $394M | $126M | · | $86M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $171M | $335M | $73M | · | · | |
| P/S | 1656.8 | 1961.4 | · | 13941.4 | · | · | · | · | · | · | · | -24623.7 | -43755.9 | 493.4 | · | 55.1 | |
| P/B | 19.7 | 22.2 | · | 12.9 | 9.7 | 9.1 | · | 13.6 | 22.9 | 13.3 | · | 4.2 | 6.5 | -11.8 | · | 13.8 | |
| P / Tangible Book | 20.3 | 23.3 | · | 13.4 | 10.1 | 9.4 | · | 14.4 | 27.3 | 15.1 | · | 4.7 | 7.1 | · | · | 125.7 | |
| P / Cash Flow | · | -100.9 | · | · | · | -80.1 | · | · | · | -49.2 | · | · | · | -19.2 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | -19025.3 | -37228.5 | 285.2 | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $350.0K | $0 | $0 | $700.0K | $1M |
| Faaliyet Kâr Marjı % | · | · | · | -8293.9% | -4443.9% |
| Net Gelir | $-73M | $-54M | $-42M | $-59M | $-64M |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | 0.0 | 0.0 | 0.0 |
| Cari Oran | · | · | 6.8 | 10.4 | 4.3 |
| Cari Oran | · | · | 6.6 | 10.2 | 3.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | $-33M | $-47M | $-55M |
Kurumsal Sahipler (13F) 112 dosya · $293.8M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
112
Tutulan Değer
$293.8M
Yeni pozisyonlar
19
Çıkan pozisyonlar
9
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 19 (-15 önceki Ç'ye göre) | 9 (-3 önceki Ç'ye göre) | 46 (+18 önceki Ç'ye göre) | 22 (-2 önceki Ç'ye göre) | +2.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $40.671.646 | 1.466.702 | 13,84% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $40.114.523 | 1.446.611 | 13,65% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $21.868.987 | 788.640 | 7,44% | Hisse senetleri |
| Portolan Capital Management, LLC | $20.889.924 | 753.333 | 7,11% | Hisse senetleri |
| Balyasny Asset Management L.P. | $19.908.670 | 717.947 | 6,78% | Hisse senetleri |
| CITADEL ADVISORS LLC | $17.373.233 | 626.514 | 5,91% | Hisse senetleri |
| VANGUARD GROUP INC | $15.360.341 | 1.118.743 | 5,23% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $14.873.582 | 536.276 | 5,06% | Hisse senetleri |
| STATE STREET CORP | $14.686.474 | 529.624 | 5,00% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $12.831.614 | 462.734 | 4,37% | Hisse senetleri |
| UBS Group AG | $7.644.302 | 275.669 | 2,60% | Hisse senetleri |
| GRIFFIN ASSET MANAGEMENT, INC. | $6.302.613 | 227.285 | 2,15% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.977.452 | 179.497 | 1,69% | Hisse senetleri |
| NORTHERN TRUST CORP | $4.813.651 | 173.590 | 1,64% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.214.710 | 151.991 | 1,43% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $3.639.646 | 131.253 | 1,24% | Hisse senetleri |
| Point72 Asset Management, L.P. | $2.952.053 | 106.457 | 1,00% | Hisse senetleri |
| NORGES BANK | $2.929.591 | 105.647 | 1,00% | Hisse senetleri |
| Nuveen, LLC | $2.819.670 | 101.683 | 0,96% | Hisse senetleri |
| Panoramic Capital, LLC | $2.719.037 | 98.054 | 0,93% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $2.268.813 | 81.818 | 0,77% | Hisse senetleri |
| Westside Investment Management, Inc. | $2.156.505 | 77.768 | 0,73% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $2.071.875 | 74.716 | 0,71% | Hisse senetleri |
| SECTORAL ASSET MANAGEMENT INC | $1.882.728 | 67.895 | 0,64% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.195.554 | 43.114 | 0,41% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $987.188 | 35.600 | 0,34% | Alım opsiyonu |
| GOLDMAN SACHS GROUP INC | $953.330 | 34.379 | 0,32% | Hisse senetleri |
| Swiss National Bank | $945.593 | 34.100 | 0,32% | Hisse senetleri |
| MORGAN STANLEY | $887.221 | 31.995 | 0,30% | Hisse senetleri |
| MANGROVE PARTNERS IM, LLC | $848.871 | 30.612 | 0,29% | Hisse senetleri |
| FORMULA GROWTH LTD | $831.900 | 30.000 | 0,28% | Hisse senetleri |
| Argo Wealth Advisory, LLC | $780.766 | 28.156 | 0,27% | Hisse senetleri |
| TIAA-CREF INDIVIDUAL & INSTITUTIONAL SERVICES, LLC | $756.974 | 27.298 | 0,26% | Hisse senetleri |
| Pandora Wealth, Inc. | $706.436 | 51.452 | 0,24% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $687.316 | 24.786 | 0,23% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $686.994 | 31.820 | 0,23% | Hisse senetleri |
| RHUMBLINE ADVISERS | $658.382 | 23.743 | 0,22% | Hisse senetleri |
| ALLSTATE CORP | $652.459 | 23.529 | 0,22% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $651.322 | 23.488 | 0,22% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $598.413 | 21.580 | 0,20% | Hisse senetleri |
| WealthTrust Axiom LLC | $596.195 | 21.500 | 0,20% | Hisse senetleri |
| Creative Planning | $583.439 | 21.040 | 0,20% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $567.883 | 20.479 | 0,19% | Hisse senetleri |
| CITADEL ADVISORS LLC | $532.416 | 19.200 | 0,18% | Alım opsiyonu |
| DIKER MANAGEMENT LLC | $527.000 | 19.000 | 0,18% | Hisse senetleri |
| Inspire Investing, LLC | $524.076 | 24.274 | 0,18% | Hisse senetleri |
| Cetera Investment Advisers | $496.755 | 17.914 | 0,17% | Hisse senetleri |
| CITADEL ADVISORS LLC | $463.091 | 16.700 | 0,16% | Satım opsiyonu |
| ALLIANCEBERNSTEIN L.P. | $449.072 | 20.800 | 0,15% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $423.714 | 15.280 | 0,14% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| ROBERT W. DUGGAN, GENIUS 24C INC, BLAZON CORPORATION ×18 başvurular | 13 Mayıs 2026 | 71,90% | Değişiklik | · | SEC |
| Christopher A. Marlett 2) ×2 başvurular | 26 Şubat 2018 | · | İlk başvuru | · | SEC |
| Christopher Marlett 2) | 01 Haziran 2016 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 23 içeriden öğrenenler · 9 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Paul A Laviolette | Chief Executive Officer | 11 Mayıs 2026 P | 15.846 | 2 | 0 | $590.700 |
| Jon Skinner | Chief Financial Officer | 03 Şubat 2025 A | · | 0 | 0 | $0 |
| Brian B Dow | CFO & SVP Admin. and Finance | 16 Mayıs 2017 A | · | 0 | 0 | $0 |
| Liane Rae Teplitsky | Chief Operating Officer | 01 Eylül 2026 P | 4.095 | 4 | 0 | $199.942 |
| Darrin Uecker | Chief Technology Officer | 23 Mart 2026 A | 284.406 | 0 | 0 | $0 |
| Kevin Patrick Danahy | Chief Commercial Officer | 18 Şubat 2026 M | 43.298 | 0 | 8 | $-3.017.438 |
| Steven Weber | Principal Accounting Officer | 14 Temmuz 2025 A | · | 0 | 0 | $0 |
| Mitchell E. Levinson | Chief Strategy Officer | 24 Eylül 2024 X | 8.521 | 0 | 0 | $0 |
| Ed Ebbers | EVP & GM, Dermatology | 01 Haziran 2021 F | 39.300 | 0 | 0 | $0 |
| Manmeet Singh Soni | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Mahkam Zanganeh | Yönetim kurulu üyesi | 11 Haziran 2026 A | 725.395 | 0 | 0 | $0 |
| Maria Sainz | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Richard Van Den Broek | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Robert W. Duggan | Yönetim kurulu üyesi | 11 Haziran 2026 A | 48.370.047 | 2 | 0 | $25.999.976 |
| Shelley D Spray | Yönetim kurulu üyesi | 25 Mayıs 2023 A | · | 0 | 0 | $0 |
| Kenneth A Clark | Yönetim kurulu üyesi | 20 Mayıs 2021 A | · | 0 | 0 | $0 |
| Thomas J M D Fogarty | Yönetim kurulu üyesi | 16 Mayıs 2019 A | · | 0 | 0 | $0 |
| Thierry B. Thaure | Yönetim kurulu üyesi | 16 Mayıs 2017 A | 0 | 0 | 0 | $0 |
| Robert J. Greenberg | Yönetim kurulu üyesi | 16 Mayıs 2017 A | 0 | 0 | 0 | $0 |
| Robert Levande | Yönetim kurulu üyesi | 16 Mayıs 2017 A | · | 0 | 0 | $0 |
| Burke Thomas Barrett | · | 11 Aralık 2024 S | 63.172 | 0 | 0 | $0 |
| Sandra A. Gardiner | · | 14 Aralık 2021 A | · | 0 | 0 | $0 |
| Laureen Debuono | · | 04 Ekim 2021 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 17 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,24% | 62.965 SH | 11 Eylül 2026 | Günlük |
| ESSC · Strategy Shares | 0,15% | 1.567 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,07% | 174.265 SH | 11 Eylül 2026 | Günlük |
| IWM · iShares Trust | 0,03% | 478.291 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 19.901 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,02% | 8.873 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 106.789 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 1.388 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 215.812 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 51.170 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 8.079 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9.573 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 39.239 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 554.612 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.637 SH | 19 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 817 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 4.024 SH | 11 Eylül 2026 | Günlük |
PLSE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 10 analist
AL
Medyan hedef
$51.50
+7,5%
3 30,0%
Güçlü Al
6 60,0%
Al
1 10,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
6 analist · 2026-10-03Ortalama hedef $54.00 +12,7%
Şimdi
Mevcut fiyat $47.90
Düşük$35.00
Ortalama$54.00
Yüksek$73.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PLSE | · | · | · | · | · | · |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| IRTC | $5.73B | -127.7 | 26.2% | -6.0% | -34.8% | 70.6% |
| ASST | · | -0.1 | 1217.5% | · | · | · |
| CHRN | $2.67B | -51.0 | -15.1% | -70.3% | -53.2% | · |
| ATRC | $1.97B | -164.8 | 14.9% | -2.1% | -2.4% | 75.0% |
| TMDX | $4.17B | 25.0 | 37.1% | 31.4% | 48.1% | 59.9% |
| BFLY | · | -12.3 | 19.0% | -79.0% | -35.9% | 46.9% |
| AXGN | $1.54B | -96.3 | 20.2% | -7.0% | -13.0% | 74.3% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Son Haberler Bu şirketten bahseden son manşetler
Pulse Biosciences CEO Satın Aldı 15.000 Şirket Hissesini. Yatırımcılar İçin Bu Ne Anlama Geliyor.
Yahoo Finance · 4 ay, 2 hafta önce
Pulse Biosciences (PLSE) Pivotal Atrial Fibrillation Trial'ında İlk Hastalarını Kaydettirdi
Yahoo Finance · 5 ay, 1 hafta önce
Pulse Biosciences Liane Teplitsky'yi CCO Olarak Atadı, David Kenigsberg'in Rolünü Tam Zamanlı CMO Olarak Genişletti
Nasdaq · 5 ay, 3 hafta önce
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026